{"denomUnitsSelected":"Participants","description":"TTNT was defined as the time from the date of first dose administration to the date of the first dose initiation of the next line of antineoplastic therapy, for any reason.","reportingStatus":"NOT_POSTED","timeFrame":"Up to 16.7 months","title":"Groups 2 and 3: Time to Next Treatment (TTNT)","type":"SECONDARY"}